509 related articles for article (PubMed ID: 18358567)
21. Life-threatening interaction between antiretroviral therapy and vinblastine in HIV-associated multicentric Castleman's disease.
Kotb R; Vincent I; Dulioust A; Peretti D; Taburet AM; Delfraissy JF; Goujard C
Eur J Haematol; 2006 Mar; 76(3):269-71. PubMed ID: 16451402
[TBL] [Abstract][Full Text] [Related]
22. Skin infections in HIV-infected individuals in the era of HAART.
Rodgers S; Leslie KS
Curr Opin Infect Dis; 2011 Apr; 24(2):124-9. PubMed ID: 21169832
[TBL] [Abstract][Full Text] [Related]
23. [Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].
Neumann T; Kondratieva J; Eggebrecht H; Wieneke H; Esser S; Bartel T; Erbel R
Herz; 2005 Sep; 30(6):504-9. PubMed ID: 16170681
[TBL] [Abstract][Full Text] [Related]
24. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy.
Werneck-Silva AL; Prado IB
J Gastroenterol Hepatol; 2009 Jan; 24(1):135-9. PubMed ID: 19054257
[TBL] [Abstract][Full Text] [Related]
25. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
[TBL] [Abstract][Full Text] [Related]
26. Oncologic complications of human immunodeficiency virus infection: changing epidemiology, treatments, and special considerations in the era of highly active antiretroviral therapy.
Klibanov OM; Clark-Vetri R
Pharmacotherapy; 2007 Jan; 27(1):122-36. PubMed ID: 17192166
[TBL] [Abstract][Full Text] [Related]
27. Critical care of HIV infected patients in the highly active antiretroviral therapy era.
Corona A; Raimondi F
Minerva Anestesiol; 2007 Dec; 73(12):635-45. PubMed ID: 18046294
[TBL] [Abstract][Full Text] [Related]
28. HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era.
Moroni M; Antinori S
AIDS; 2003 Apr; 17 Suppl 1():S51-64. PubMed ID: 12870531
[TBL] [Abstract][Full Text] [Related]
29. When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience.
Loubiere S; el Filal KM; Sodqi M; Loundou A; Luchini S; Cleary S; Moatti JP; Himmich H
Antivir Ther; 2008; 13(2):241-51. PubMed ID: 18505175
[TBL] [Abstract][Full Text] [Related]
30. Life-threatening complications of HIV infection.
Davaro RE; Thirumalai A
J Intensive Care Med; 2007; 22(2):73-81. PubMed ID: 17456727
[TBL] [Abstract][Full Text] [Related]
31. Declining gastrointestinal opportunistic infections in HIV-infected persons: a triumph of science and a challenge for our HAARTs and minds.
Raufman JP
Am J Gastroenterol; 2005 Jul; 100(7):1455-8. PubMed ID: 15984965
[TBL] [Abstract][Full Text] [Related]
32. Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness.
Vergara-Rodriguez P; Vibhakar S; Watts J
Pharmacol Ther; 2009 Dec; 124(3):269-78. PubMed ID: 19647020
[TBL] [Abstract][Full Text] [Related]
33. HIV infection and complications in emergency medicine.
Marco CA; Rothman RE
Emerg Med Clin North Am; 2008 May; 26(2):367-87, viii-ix. PubMed ID: 18406979
[TBL] [Abstract][Full Text] [Related]
34. [Cutaneous drug reactions in HIV-infected patients in the HAART era].
Blanes M; Belinchón I; Portilla J
Actas Dermosifiliogr; 2009 May; 100(4):253-65. PubMed ID: 19463228
[TBL] [Abstract][Full Text] [Related]
35. Highly active antiretroviral therapy and the kidney: an update on antiretroviral medications for nephrologists.
Berns JS; Kasbekar N
Clin J Am Soc Nephrol; 2006 Jan; 1(1):117-29. PubMed ID: 17699198
[TBL] [Abstract][Full Text] [Related]
36. HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors.
Jones R; Gazzard B
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):303-12. PubMed ID: 16597210
[TBL] [Abstract][Full Text] [Related]
37. Clinical cardiac manifestations of HIV infection: a review of current literature.
Chu WW; Sosman JM; Stein JH
WMJ; 2002; 101(7):40-5, 39. PubMed ID: 12426919
[TBL] [Abstract][Full Text] [Related]
38. Toxicities of antiretroviral therapy in children.
Nwaobasi E; Oleske JM
AIDS Read; 2006 Oct; 16(10):537-40, 544-6,549-50, 552-4. PubMed ID: 17096472
[TBL] [Abstract][Full Text] [Related]
39. HIV and cardiovascular risk factors.
Falusi OM; Aberg JA
AIDS Read; 2001 May; 11(5):263-8. PubMed ID: 11392695
[TBL] [Abstract][Full Text] [Related]
40. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.
Crook M
Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
